Capecitabine: Have we got the dose right?
In the past 5-10 years there has been a growing trend for substituting conventional 5-fluorouracil with the oral prodrug of 5-fluorouracil, capecitabine, in chemotherapy regimens. This regimen change is based on evidence of the efficacy equivalence of these two drugs and the lack of an increase in o...
Main Authors: | , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Search Result 1
Search Result 2